Benefiting from the national medical insurance policy, Ailis expects a 43.73% year-on-year increase in net profit by 2025.

On March 3rd, Ailisi (688578.SH) disclosed its first-quarter 2026 earnings forecast. It is expected that the first quarter will achieve operating revenue of 1,550 million yuan, an increase of 451.63 million yuan from the same period last year, a year-on-year growth of 41.12%. The net profit attributable to the owners of the parent company is projected to be 590 million yuan, an increase of 179.5 million yuan from the same period last year, a year-on-year growth of 43.73%. The net profit attributable to the owners of the parent company after deducting non-recurring gains and losses is expected to be 570 million yuan, an increase of 174.16 million yuan from the same period last year, a year-on-year growth of 44.00%. In the same period last year, the company achieved a total profit of 475.76 million yuan, net profit attributable to the owners of the parent company was 410.50 million yuan, and net profit attributable to the owners of the parent after deducting non-recurring gains and losses was 395.84 million yuan. Basic earnings per share were 0.91 yuan.

The main reason for the change in performance this period is due to the support and coverage of national medical insurance policies, with continuous growth in the sales revenue of commercialized products and promotional services, driving the company’s operating performance to continue climbing.